Intestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in Parkinson’s disease S Hasegawa, S Goto, H Tsuji, T Okuno, T Asahara, K Nomoto, A Shibata, ... PloS one 10 (11), e0142164, 2015 | 525 | 2015 |
Increase of deleted mitochondrial DNA in the striatum in Parkinson's disease and senescence S Ikebe, M Tanaka, K Ohno, W Sato, K Hattori, T Kondo, Y Mizuno, ... Biochemical and biophysical research communications 170 (3), 1044-1048, 1990 | 459 | 1990 |
CHCHD2 mutations in autosomal dominant late-onset Parkinson's disease: a genome-wide linkage and sequencing study M Funayama, K Ohe, T Amo, N Furuya, J Yamaguchi, S Saiki, Y Li, ... The Lancet Neurology 14 (3), 274-282, 2015 | 384 | 2015 |
Human branch point consensus sequence is yUnAy K Gao, A Masuda, T Matsuura, K Ohno Nucleic acids research 36 (7), 2257-2267, 2008 | 338 | 2008 |
Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans K Ohno, A Tsujino, JM Brengman, CM Harper, Z Bajzer, B Udd, R Beyring, ... Proceedings of the National Academy of Sciences 98 (4), 2017-2022, 2001 | 318 | 2001 |
Mutation of the acetylcholine receptor α subunit causes a slow-channel myasthenic syndrome by enhancing agonist binding affinity SM Sine, K Ohno, C Bouzat, A Auerbach, M Milone, JN Pruitt, AG Engel Neuron 15 (1), 229-239, 1995 | 318 | 1995 |
Myofibrillar myopathy: clinical, morphological and genetic studies in 63 patients D Selcen, K Ohno, AG Engel Brain 127 (2), 439-451, 2004 | 314 | 2004 |
Meta‐analysis of gut dysbiosis in Parkinson's disease H Nishiwaki, M Ito, T Ishida, T Hamaguchi, T Maeda, K Kashihara, ... Movement Disorders 35 (9), 1626-1635, 2020 | 309 | 2020 |
Congenital myasthenic syndrome caused by prolonged acetylcholine receptor channel openings due to a mutation in the M2 domain of the epsilon subunit. K Ohno, DO Hutchinson, M Milone, JM Brengman, C Bouzat, SM Sine, ... Proceedings of the National Academy of Sciences 92 (3), 758-762, 1995 | 308 | 1995 |
Beneficial biological effects and the underlying mechanisms of molecular hydrogen-comprehensive review of 321 original articles M Ichihara, S Sobue, M Ito, M Ito, M Hirayama, K Ohno Medical gas research 5, 1-21, 2015 | 292 | 2015 |
Rapsyn mutations in humans cause endplate acetylcholine-receptor deficiency and myasthenic syndrome K Ohno, AG Engel, XM Shen, D Selcen, J Brengman, CM Harper, ... The American Journal of Human Genetics 70 (4), 875-885, 2002 | 283 | 2002 |
Human endplate acetylcholinesterase deficiency caused by mutations in the collagen-like tail subunit (ColQ) of the asymmetric enzyme K Ohno, J Brengman, A Tsujino, AG Engel Proceedings of the National Academy of Sciences 95 (16), 9654-9659, 1998 | 283 | 1998 |
Progression of Parkinson's disease is associated with gut dysbiosis: two-year follow-up study T Minato, T Maeda, Y Fujisawa, H Tsuji, K Nomoto, K Ohno, M Hirayama PloS one 12 (11), e0187307, 2017 | 281 | 2017 |
Congenital myasthenic syndrome caused by decreased agonist binding affinity due to a mutation in the acetylcholine receptor ε subunit K Ohno, HL Wang, M Milone, N Bren, JM Brengman, S Nakano, P Quiram, ... Neuron 17 (1), 157-170, 1996 | 272 | 1996 |
Molecular hydrogen is protective against 6-hydroxydopamine-induced nigrostriatal degeneration in a rat model of Parkinson's disease Y Fu, M Ito, Y Fujita, M Ito, M Ichihara, A Masuda, Y Suzuki, S Maesawa, ... Neuroscience letters 453 (2), 81-85, 2009 | 271 | 2009 |
Position-dependent FUS-RNA interactions regulate alternative splicing events and transcriptions S Ishigaki, A Masuda, Y Fujioka, Y Iguchi, M Katsuno, A Shibata, F Urano, ... Scientific reports 2 (1), 529, 2012 | 270 | 2012 |
New mutations in acetylcholine receptor subunit genes reveal heterogeneity in the slow-channel congenital myasthenic syndrome AG Engel, K Ohno, M Milone, HL Wang, S Nakano, C Bouzat, JN Pruitt, ... Human molecular genetics 5 (9), 1217-1227, 1996 | 253 | 1996 |
Peroxisome targeting signal of rat liver acyl-coenzyme A oxidase resides at the carboxy terminus S Miyazawa, T Osumi, T Hashimoto, K Ohno, S Miura, Y Fujiki Molecular and cellular biology, 1989 | 244 | 1989 |
CUGBP1 and MBNL1 preferentially bind to 3′ UTRs and facilitate mRNA decay A Masuda, HS Andersen, TK Doktor, T Okamoto, M Ito, BS Andresen, ... Scientific reports 2 (1), 209, 2012 | 225 | 2012 |
Quantitative determination of deleted mitochondrial DNA relative to normal DNA in parkinsonian striatum by a kinetic PCR analysis T Ozawa, M Tanaka, S Ikebe, K Ohno, T Kondo, Y Mizuno Biochemical and biophysical research communications 172 (2), 483-489, 1990 | 222 | 1990 |